{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:21Z","timestamp":1792110261149,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ghir.2004.03.030","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T06:36:08Z","timestamp":1084257368000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"special_numbering":"S","title":["Pathogenesis of retinopathy of prematurity"],"prefix":"10.1016","volume":"14","author":[{"given":"Lois E.H.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2004.03.030_BIB1","series-title":"Retrolental Fibroplasia: A Modern Parable","year":"1980"},{"key":"10.1016\/j.ghir.2004.03.030_BIB2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5694\/j.1326-5377.1951.tb109040.x","article-title":"Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach","volume":"2","author":"Campbell","year":"1951","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ghir.2004.03.030_BIB3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archopht.1952.00920010086012","article-title":"Prevention of retrolental fibroplasia","volume":"48","author":"Crosse","year":"1952","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasia: I. Nursery observations","volume":"35","author":"Patz","year":"1952","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1542\/peds.60.5.655","article-title":"PaO2 levels and retrolental fibroplasia: a report of the cooperative study","volume":"60","author":"Kinsey","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2004.03.030_BIB6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.67.6.924","article-title":"Retinopathy of prematurity: An estimate of visual loss in the United States-1979","volume":"67","author":"Phelps","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2004.03.030_BIB7","first-page":"549","article-title":"Acute proliferative retrolental fibroplasia: multivariate risk analysis","volume":"81","author":"Flynn","year":"1983","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.ghir.2004.03.030_BIB8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0002-9394(77)90377-4","article-title":"Retinal vascular development in premature infants","volume":"84","author":"Roth","year":"1977","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB9","first-page":"117","article-title":"Development of retinal vasculature in paranatal infants","volume":"18","author":"Foos","year":"1973","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB10","first-page":"137","article-title":"The mode of development of the vascular system of the retina, with some observations in its significance for certain retinal diseases","volume":"68","author":"Michaelson","year":"1948","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"10.1016\/j.ghir.2004.03.030_BIB11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9394(66)91322-5","article-title":"Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor Lecture","volume":"62","author":"Ashton","year":"1966","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB13","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ghir.2004.03.030_BIB14","first-page":"3429","article-title":"Oxygen-induced retinopathy in the rat: Relationship of retinal nonperfusion to subsequent neovascularization","volume":"35","author":"Penn","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ghir.2004.03.030_BIB15","first-page":"1322","article-title":"Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy","volume":"37","author":"McLeod","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ghir.2004.03.030_BIB16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/359845a0","article-title":"Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo","volume":"359","author":"Plate","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2004.03.030_BIB17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2004.03.030_BIB18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2004.03.030_BIB19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2004.03.030_BIB20","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.93.10.4851","article-title":"Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy","volume":"93","author":"Robinson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2004.03.030_BIB21","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2004.03.030_BIB22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/02713689608997411","article-title":"Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy","volume":"15","author":"Donahue","year":"1996","journal-title":"Current Eye Res."},{"key":"10.1016\/j.ghir.2004.03.030_BIB23","first-page":"290","article-title":"Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity","volume":"37","author":"Stone","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ghir.2004.03.030_BIB24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1091-8531(97)90008-2","article-title":"Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity","volume":"1","author":"Young","year":"1997","journal-title":"J. Aapos."},{"key":"10.1016\/j.ghir.2004.03.030_BIB25","first-page":"574","article-title":"Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model","volume":"145","author":"Miller","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","article-title":"Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate","volume":"114","author":"Adamis","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB27","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders [see comments]","volume":"331","author":"Aiello","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.03.030_BIB28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy","volume":"118","author":"Adamis","year":"1994","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB29","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ghir.2004.03.030_BIB30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity [see comments] [published erratum appears in Arch. Ophthalmol. 115(3) (1997) Mar. 427]","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.03.030_BIB31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/j.ghir.2004.03.030_BIB32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diab.2.1.7","article-title":"Simmon's disease with resolution of proliferative diabetic retinopathy","volume":"2","author":"Poulsen","year":"1953","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.03.030_BIB33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00270416","article-title":"Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy","volume":"30","author":"Sharp","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.03.030_BIB34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/bmj.2.5653.346","article-title":"Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation","volume":"2","author":"Wright","year":"1969","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ghir.2004.03.030_BIB35","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.276.5319.1706","article-title":"Essential role of growth hormone in ischemia-induced retinal neovascularization","volume":"276","author":"Smith","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ghir.2004.03.030_BIB36","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nature Med."},{"key":"10.1016\/j.ghir.2004.03.030_BIB37","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2004.03.030_BIB38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstrom","year":"2003","journal-title":"Pediatrics"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:41:29Z","timestamp":1761086489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637404000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":38,"alternative-id":["S1096637404000619"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2004.03.030","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2004.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}